Huntleigh Advisors »

Olema Pharmaceuticals shares owned by Huntleigh Advisors

Quarter-by-quarter ownership of Olema Pharmaceuticals (OLMA) shares owned by Huntleigh Advisors from 13F filings

Historical chart of Huntleigh Advisors investment in Olema Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Olema Pharmaceuticals held by Huntleigh Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Olema Pharmaceuticals by Huntleigh Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $503k 20k 25.00

More positions owned by Huntleigh Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Ab Active Etfs Short Duration H (SYFI)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amphenol Corp Cl A (APH)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Victory Portfolios Ii Core Intrmediate (UBND)
Blackrock (BLK)
Pgim Etf Tr Total Return Bon (PTRB)

View all positions for Huntleigh Advisors

Top funds holding Olema Pharmaceuticals

Bain Capital Life Sciences Investors
Paradigm Biocapital Advisors
BlackRock
BVF
Henderson Group
Vanguard Group
Siren
Logos Global Management
Cormorant Asset Management
Franklin Resources
Lightspeed Management Company
State Street Corporation
Vestal Point Capital
Woodline Partners
Polar Capital Holdings

View all funds holding Olema Pharmaceuticals